PGHL

Procter & Gamble Health Share Price

₹5,094.80 -24.8 (-0.48%)

23 Nov, 2024 00:16

SIP TrendupStart SIP in PGHL

Start SIP

Performance

  • Low
  • ₹5,079
  • High
  • ₹5,171
  • 52 Week Low
  • ₹4,637
  • 52 Week High
  • ₹5,833
  • Open Price₹5,120
  • Previous Close₹5,120
  • Volume4,499

Investment Returns

  • Over 1 Month -1.28%
  • Over 3 Month -5.19%
  • Over 6 Month + 6.71%
  • Over 1 Year -1.24%
SIP Lightning

Smart Investing Starts Here Start SIP with Procter & Gamble Health for Steady Growth!

Invest Now

Procter & Gamble Health Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 38.8
  • PEG Ratio
  • -6.6
  • Market Cap Cr
  • 8,457
  • P/B Ratio
  • 15.7
  • Average True Range
  • 162.94
  • EPS
  • 136.52
  • Dividend Yield
  • 4.9
  • MACD Signal
  • 11.93
  • RSI
  • 41.76
  • MFI
  • 67.64

Procter & Gamble Health Financials

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹5,094.80
-24.8 (-0.48%)
pointer
  • stock-down_img
  • Bullish Moving Average 1
  • stock-up_img
  • Bearish Moving Average 15
  • 20 Day
  • ₹5,251.31
  • 50 Day
  • ₹5,249.52
  • 100 Day
  • ₹5,205.21
  • 200 Day
  • ₹5,132.85

Resistance and Support

5114.9 Pivot Speed
  • R3 5,242.25
  • R2 5,206.50
  • R1 5,150.65
  • S1 5,059.05
  • S2 5,023.30
  • S3 4,967.45

What's your outlook on Procter & Gamble Health?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

P&G Health is a leading global healthcare company specializing in consumer health products, including over-the-counter medications and dietary supplements. With a focus on innovation and quality, it aims to enhance the well-being of individuals and families worldwide.

Procter & Gamble Health has an operating revenue of Rs. 1,159.74 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 24% is great, ROE of 37% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -8% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Procter & Gamble Health Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-04 Quarterly Results
2024-08-21 Audited Results & Final Dividend
2024-05-02 Quarterly Results
2024-02-06 Quarterly Results & Interim Dividend
2023-11-03 Quarterly Results
Date Purpose Remarks
2024-02-14 INTERIM Rs.50.00 per share(500%)Interim Dividend
2024-02-14 SPECIAL Rs.150.00 per share(1500%)Special Dividend
2023-02-13 INTERIM Rs.45.00 per share(450%)Interim Dividend
2022-05-13 INTERIM Rs.41.00 per share(410%)Interim Dividend

Procter & Gamble Health F&O

Procter & Gamble Health Shareholding Pattern

51.82%
10.45%
4.09%
6.61%
0%
21.46%
5.57%

About Procter & Gamble Health

  • NSE Symbol
  • PGHL
  • BSE Symbol
  • 500126
  • Managing Director
  • Mr. Milind Thatte
  • ISIN
  • INE199A01012

Similar Stocks to Procter & Gamble Health

Procter & Gamble Health FAQs

Procter & Gamble Health share price is ₹5,094 As on 23 November, 2024 | 00:02

The Market Cap of Procter & Gamble Health is ₹8457.1 Cr As on 23 November, 2024 | 00:02

The P/E ratio of Procter & Gamble Health is 38.8 As on 23 November, 2024 | 00:02

The PB ratio of Procter & Gamble Health is 15.7 As on 23 November, 2024 | 00:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23